ATE406363T1 - Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten - Google Patents

Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten

Info

Publication number
ATE406363T1
ATE406363T1 AT04739120T AT04739120T ATE406363T1 AT E406363 T1 ATE406363 T1 AT E406363T1 AT 04739120 T AT04739120 T AT 04739120T AT 04739120 T AT04739120 T AT 04739120T AT E406363 T1 ATE406363 T1 AT E406363T1
Authority
AT
Austria
Prior art keywords
sup
alpha
methylpyrrolopyridines
methylindoles
adrenergic agonists
Prior art date
Application number
AT04739120T
Other languages
English (en)
Inventor
Michael Dillon
Clara Lin
Amy Moore
Counde O'yang
Yansheng Zhai
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE406363T1 publication Critical patent/ATE406363T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT04739120T 2003-05-09 2004-04-30 Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten ATE406363T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46925503P 2003-05-09 2003-05-09

Publications (1)

Publication Number Publication Date
ATE406363T1 true ATE406363T1 (de) 2008-09-15

Family

ID=33435226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04739120T ATE406363T1 (de) 2003-05-09 2004-04-30 Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten

Country Status (15)

Country Link
US (1) US6979696B2 (de)
EP (1) EP1660484B1 (de)
JP (1) JP4454622B2 (de)
KR (1) KR100751163B1 (de)
CN (1) CN100378097C (de)
AT (1) ATE406363T1 (de)
AU (1) AU2004235923B2 (de)
BR (1) BRPI0410237A (de)
CA (1) CA2523253C (de)
DE (1) DE602004016177D1 (de)
ES (1) ES2313019T3 (de)
MX (1) MXPA05011841A (de)
PL (1) PL1660484T3 (de)
RU (1) RU2313524C2 (de)
WO (1) WO2004099189A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05004929A (es) * 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
TW200602317A (en) * 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
CA2624220A1 (en) * 2005-09-29 2007-04-12 Wyeth 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
JP2009517432A (ja) * 2005-11-30 2009-04-30 エフ．ホフマン−ラ ロシュ アーゲー ３−アミノ−２−アリールプロピルアザインドールおよびその使用
LT2658844T (lt) 2010-12-28 2017-02-10 Sanofi Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių
CN102702196B (zh) * 2012-06-13 2015-01-14 南京药石药物研发有限公司 3-甲基-7-氮杂吲哚的合成方法
KR102129842B1 (ko) * 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
WO2016014426A1 (en) * 2014-07-21 2016-01-28 The Arizona Board Of Regents Organic reactions
JP7688785B2 (ja) * 2022-10-14 2025-06-04 株式会社三和化学研究所 イミダゾール誘導体
WO2024254218A2 (en) * 2023-06-05 2024-12-12 The Board Of Regents Of The University Of Texas System Non-peptide small molecule fgf14:nav1.6 channel complex protein-protein interaction modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370063A (en) * 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US3586695A (en) * 1968-01-26 1971-06-22 Dow Chemical Co Substituted imidazolinyl indoles
GB9011335D0 (en) 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5767133A (en) 1993-06-14 1998-06-16 Pfizer Inc. Secondary amines as antidiabetic and antiobesity agents
JPH0887346A (ja) * 1994-09-14 1996-04-02 Chino Kogyo:Kk パソコン等デスク上を活用する為の卓上台座器具
EA199900375A1 (ru) 1996-11-14 1999-12-29 Пфайзер Инк. Способ получения замещенных пиридинов
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
GB9910110D0 (en) * 1999-04-30 1999-06-30 Glaxo Group Ltd Chemical compounds
CA2403806A1 (en) 2000-03-23 2002-09-20 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
DE10106214A1 (de) * 2001-02-10 2002-08-14 Boehringer Ingelheim Pharma Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
EP1501826B1 (de) * 2002-02-01 2006-09-27 F. Hoffman-la Roche AG Substituierte indole als alpha-1 agonisten

Also Published As

Publication number Publication date
CN100378097C (zh) 2008-04-02
US20040224973A1 (en) 2004-11-11
CA2523253A1 (en) 2004-11-18
RU2005138143A (ru) 2006-08-10
KR20060015590A (ko) 2006-02-17
KR100751163B1 (ko) 2007-08-22
DE602004016177D1 (de) 2008-10-09
RU2313524C2 (ru) 2007-12-27
ES2313019T3 (es) 2009-03-01
BRPI0410237A (pt) 2006-05-09
CA2523253C (en) 2010-06-22
WO2004099189A1 (en) 2004-11-18
MXPA05011841A (es) 2006-01-26
PL1660484T3 (pl) 2009-02-27
EP1660484B1 (de) 2008-08-27
JP2006525970A (ja) 2006-11-16
JP4454622B2 (ja) 2010-04-21
EP1660484A1 (de) 2006-05-31
AU2004235923B2 (en) 2008-01-24
AU2004235923A1 (en) 2004-11-18
US6979696B2 (en) 2005-12-27
CN1784397A (zh) 2006-06-07

Similar Documents

Publication Publication Date Title
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
DE60208568D1 (de) Prostaglandinanaloga als ep4-rezeptoragonisten
DE602004006165D1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
DE60309829D1 (de) Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
NO20023932D0 (no) Nye forbindelser
SE0302760D0 (sv) New compounds
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
TW200508207A (en) New benzimidazole derivatives
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
SE0403171D0 (sv) New compounds
ATE386725T1 (de) Heterocyclylverbindungen
ATE417838T1 (de) Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
PL374019A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
MXPA04005076A (es) Derivados de 4-piperidinil alquilamina como antagonistas del receptor muscarinico.
DE602004016177D1 (de) Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten
MXPA04005313A (es) Derivados de aminotetralin como antagonistas del receptor muscarinico.
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren
MXPA05011476A (es) Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2.
SE0403118D0 (sv) New compounds 2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1660484

Country of ref document: EP